UBS AG - IMMUCELL CORP ownership

IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 13 filers reported holding IMMUCELL CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of IMMUCELL CORP
ValueSharesWeighting
Q3 2014$10,000
+25.0%
1,962
+5.9%
0.00%
Q2 2014$8,000
+60.0%
1,852
+85.2%
0.00%
Q1 2014$5,000
-28.6%
1,000
-41.1%
0.00%
Q4 2013$7,000
-56.2%
1,697
-48.9%
0.00%
Q3 2013$16,000
+128.6%
3,322
+77.6%
0.00%
Q2 2013$7,0001,8700.00%
Other shareholders
IMMUCELL CORP shareholders Q4 2013
NameSharesValueWeighting ↓
PERRITT CAPITAL MANAGEMENT INC 154,300$1,285,0000.38%
HEARTLAND ADVISORS INC 199,600$1,663,0000.11%
Minerva Advisors LLC 14,559$121,0000.06%
Essex Financial Services, Inc. 23,776$198,0000.04%
SHUFRO ROSE & CO LLC 50,791$423,0000.04%
INGALLS & SNYDER LLC 91,511$762,0000.03%
RBF Capital, LLC 13,086$109,0000.01%
FLAGSHIP HARBOR ADVISORS, LLC 3,000$26,0000.01%
Renaissance Technologies 96,100$801,0000.00%
MORGAN STANLEY 11,732$98,0000.00%
View complete list of IMMUCELL CORP shareholders